Fibroblasts are a main player in the
tumor-inhibitory microenvironment. Upon
tumor initiation and progression, fibroblasts can lose their
tumor-inhibitory capacity and promote
tumor growth. The molecular mechanisms that underlie this switch have not been defined completely. Previously, we identified four
proteins overexpressed in cancer-associated fibroblasts and linked to
Rho GTPase signaling. Here, we show that knocking out the
Ras homolog family member A (RhoA) gene in normal fibroblasts decreased their
tumor-inhibitory capacity, as judged by neighbor suppression in vitro and accompanied by promotion of
tumor growth in vivo. This also induced PC3
cancer cell motility and increased colony size in 2D cultures. RhoA knockout in fibroblasts induced
vimentin intermediate filament reorganization, accompanied by reduced contractile force and increased stiffness of cells. There was also loss of wide
F-actin stress fibers and large focal adhesions. In addition, we observed a significant loss of α-smooth muscle actin, which indicates a difference between RhoA knockout fibroblasts and classic cancer-associated fibroblasts. In 3D
collagen matrix, RhoA knockout reduced fibroblast branching and meshwork formation and resulted in more compactly clustered
tumor-cell colonies in coculture with PC3 cells, which might boost
tumor stem-like properties. Coculturing RhoA knockout fibroblasts and PC3 cells induced expression of proinflammatory genes in both. Inflammatory mediators may induce
tumor cell stemness. Network enrichment analysis of transcriptomic changes, however, revealed that the Rho signaling pathway per se was significantly triggered only after coculturing with
tumor cells. Taken together, our findings in vivo and in vitro indicate that Rho signaling governs the inhibitory effects by fibroblasts on
tumor-cell growth.